Supplementary Figure S1 from MTORC1/2 Inhibition as a Therapeutic Strategy for PIK3CA Mutant Cancers
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Figure S1 presents the viability of SW48 and SW48PK cells after treatment with BEZ235 and TAK-228 at the 100-400nM concentrations.
Authors: Stephanie L. Fricke, Susan N. Payne, Peter F. Favreau, Jeremy D. Kratz, Cheri A. Pasch, Tyler M. Foley, Alexander E. Yueh, Dana R. Van De Hey, Mitchell G. Depke, Demetra P. Korkos, Gioia Chengcheng Sha, Rebecca A. DeStefanis, Linda Clipson, Mark E. Burkard, Kayla K. Lemmon, Benjamin M. Parsons, Paraic A. Kenny, Kristina A. Matkowskyj, Michael A. Newton, Melissa C. Skala, Dustin A. Deming
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4362494163